Posts

Showing posts with the label H2

Metabotropic Glutamate Receptor 4 - Pipeline Review, H2 Market analysis, supply and demand report to 2016

Radiant insights, inc, 'Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2016', provides in depth analysis on Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted pipeline therapeutics. The report provides comprehensive information on the Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics development and features dormant and discontinued projects. Download full research Report @ http://www.radiantinsights.com/research/metabotropic-glutamat...